Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
4.125
-0.035 (-0.84%)
Nov 28, 2025, 4:00 PM EST - Market closed
Adverum Biotechnologies Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$11.60
Upside
+181.21%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $30 → $5 | Strong Buy → Hold | Downgrades | $30 → $5 | +21.21% | Nov 17, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $3 → $4 | Hold | Maintains | $3 → $4 | -3.03% | Oct 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +627.27% | Sep 23, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $33 | Strong Buy | Maintains | $33 | +700.00% | Aug 13, 2025 |
| Mizuho | Mizuho | Buy Maintains $16 → $12 | Buy | Maintains | $16 → $12 | +190.91% | Jun 26, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | -3.03% | May 15, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $33 | Strong Buy | Maintains | $33 | +700.00% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +627.27% | May 15, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $40 → $33 | Strong Buy | Maintains | $40 → $33 | +700.00% | Apr 17, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $10 → $5 | Hold | Maintains | $10 → $5 | +21.21% | Apr 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +627.27% | Apr 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +627.27% | Nov 19, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $12 → $10 | Hold | Maintains | $12 → $10 | +142.42% | Nov 5, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $60 → $40 | Strong Buy | Maintains | $60 → $40 | +869.70% | Aug 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +627.27% | Aug 13, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $15 → $12 | Hold | Maintains | $15 → $12 | +190.91% | Aug 13, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.